whatshot

RNAC   $7.87  5.92% Market Open

Cartesian Therapeutics, Inc.
show_chart Advanced Chart of RNAC

Current temperature: 17.96
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 6
Target Price Mean 33.83
Mean unverified/preliminary 33.83 / 33.83
Target Price Low / High 16.00 / 44.00
Median / STD DEV 39.00 / 10.89
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell None Sell
rsi Sell Sell Sell
macd None None None
stoch None None None
ma20 Sell ActivelyBuy None
ma50 None None None
ma100 None None Sell
Candlestick PatternJune 8, 2026 Bullish Harami - consists of an unusually large black body followed by a small white body contained within large black body. It is considered as a bullish pattern when preceded by a downtrend.
ISIN US8162123025
ceo Dr. Carsten Brunn Ph.D.
Website https://www.cartesiantherapeutics.com
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, engages in the provision of mRNA cell therapies for the treatment of autoimmune diseases. It develops Descartes-08, an autologous anti-BCMA RNA-engineered chimeric antigen receptor T-cell therapy, currently under Phase 2b clinical development for generalized myasthenia gravis, as well as for patients with systemic lupus erythematosus, and myeloma autoimmune basket trials for other autoimmune diseases. The company develops Descartes-15 to treat Autoimmune diseases, myeloma; and Descartes-33 which is in preclinical development for treatment of autoimmune diseases. Cartesian Therapeutics, Inc. is headquartered in Gaithersburg, Maryland.